Audited Results of Beryl Drugs Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	21.15	26.73	26.89	14.60	14.09
Manufacturing Expenses	3.71	4.46	3.89	1.95	1.95
Personnel Expenses	2.21	1.93	1.70	1.31	1.18
Selling Expenses	0.02	0.01	0.02	0.01	0.01
Administrative Expenses	3.04	4.75	4.66	2.42	2
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	19.91	24.45	24.94	14.20	12.64
Operating Profit	1.23	2.28	1.95	0.41	1.45
Other Recurring Income	1.41	0.40	0.27	0.16	0.19
Adjusted PBDIT	2.64	2.67	2.21	0.57	1.64
Financial Expenses	0.53	0.46	0.42	0.44	0.47
Depreciation	1.25	1.20	0.81	1.09	1.27
Other Write offs	0	0	0	0	0
Adjusted PBT	0.87	1.01	0.98	-0.95	-0.10
Tax Charges	0.29	0.24	0.22	-0.29	0.11
Adjusted PAT	0.58	0.77	0.77	-0.66	-0.21
Non Recurring Items	0	0	0	0	0.45
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	0.58	0.77	0.77	-0.66	0.24
Equity Dividend	0	0	0	0	0
Preference Dividend	0	0	0	0	0
Retained Earnings	4.35	3.77	3	2.23	2.89

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article